Join us Sept. 14-16 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
OpenAI builds offerings on consent as it expands ChatGPT ads to Europe
The company’s new EU privacy policy goes live “later this month”.
ANA updates efforts to standardize retail media network measurement
The ANA is hammering out guidelines around standardization of retail media measurement, on behalf of its member base of marketers
How DTC startups are using AI to scale more efficiently
Brand marketers are recreating the DTC playbook for the current agentic AI landscape.